Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Melanoma 2Neoplasm Metastasis 1Feasibility 1

Interventions

pertuzumab 1Vemurafenib 1Trastuzumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Feasibility × Vemurafenib × Clear all
NCT05177666 2022-01-04

a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors

The University of Hong Kong-Shenzhen Hospital

Unknown
120 enrolled

Feasibility

Data powered by HemOnc (CC BY 4.0) Colophon âš¡